Prophylactic Donor Lymphocyte Infusion in Patients after Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide Is Associated with Low Relapse Risk and Excellent Survival in Patients below 65 Years with Acute Myeloid Leukemia and High-Risk Myelodysplasia

Autor: Von Dem Borne, Peter A., Snijders, Tjeerd J.F. *, van Lammeren, Danielle, Tijmensen, Janneke *, Planken, Erwin V. *, Levenga, Henriette *, van den Berg, Yascha *, Marijt, Erik WAF, van Balen, Peter, Tjon, Jennifer M. *, Vermaat, Joost S.P., Nering Bögel, Theo L. *, Oudshoorn, Mirjam A. *, Halkes, Constantijn J.M., Veelken, Hendrik
Zdroj: In Blood 15 November 2022 140 Supplement 1:7742-7743
Databáze: ScienceDirect